All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance

The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Steering CommitteeAbout UsNewsletterContact
Visit:
ALL hubAML HubGVhD HubLymphoma HubMPN HubMultiple Myeloma Hub
Steering CommitteeAbout UsNewsletterContact
TypesTherapeuticsCongressesTrialsExpert Opinions
IACH 2021

Practice-changing abstracts in myelodysplastic syndromes

By David Bowen, Mikkael A. Sekeres, Moshe Mittelman, Pierre Fenaux, Rafael Bejar, Rena Buckstein, Silvia Magalhães, Theo de Witte, Uwe Platzbecker, Yasushi Miyazaki
Feb 8, 2021
Share:

World-leading experts in MDS shared the top abstracts from the 62nd American Society Hematology (ASH)  Annual Meeting and Exposition that they believed could have the greatest impact on clinical practice.

Did you miss ASH 2020? In this downloadable resource, we present comments from MDS Hub Steering Committee members on improving the treatment of patients with low- and high-risk MDS, as well as improving the diagnosis/prognosis in MDS.

ASH 2020 | Practice-changing abstracts in myelodysplastic syndromes

Did you miss ASH 2020? Download the resource below to view our Steering Committee's selection of practice-changing abstracts in MDS.

Download Here
Share:
More about...
ASHASH 2020Myelodysplastic syndromes

Related articles

Newsletter

Subscribe to get the best content related to MDS delivered to your inbox